GLYNVAIR
GLYCOPYRRONIUM · by HIGHNOON
Composition
Per cap: Glycopyrronium 50 mg inhalation powder; caps for use by inhalation device for inhalation
Indications & Dosage
Maintenance treatment of chronic obstructive pulmonary disease: BY INHALATION: Adult: 1 inhalation daily to be administered at the same time of the day each day.
Precautions
Cardiovascular or convulsive disorders, ischaemic heart disease, left ventricular failure, MI, arrhythmias, renal or hepatic impairment, risk of paradoxical bronchospasm (discontinue immediately). Narrow angle glaucoma, uninary retention. If a dose is missed, it should be taken as soon as possible on the same day. Patients should be instructed not to take more than one dose in a day.
Interactions
Anticholinergics
Side Effects
Headache, dizzines, nasopharyngitis, urinary tract infection, paradoxical bronchospasm, insomnia, gastroenteritis, urinary retention, oedema peripheral, pyrexia. Rare: Ischaemic heart disease, atrial fibrillation, tachycardia, palpitations, glaucoma